Some of these 11 fatty acid metabolism genes have been previously reported, and the results of Song et al.'s analysis of selective splicing signals of more than 10,000 genes in ccRCC demonstrated that SCD5 is one of the potential markers of tumor prognosis (Song et al., 2019). This evidence concerns the gene SCD5 and nonpapillary renal cell carcinoma.